MedTrace Logo

Diabetes In Relation to Hospitalized COVID-19 Patents At Assiut University Hospital

NCT05083013 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2021-10-19

No results posted yet for this study

Summary

Coronavirus disease (COVID-19), a global pandemic affecting the whole world and taking the lives of millions. The majority of fatalities occur in the elderly specially in the presence of chronic diseases such as diabetes mellitus (DM), hypertension, obesity, cardiovascular disease, chronic kidney disease and cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

Reverse transcription polymerase chain reaction (RT-PCR)

For SARS Corona Virus 2 (COV2) confirmation

DIAGNOSTIC_TEST

Glycated haemoglobin (HbA1C)

Diabetic patients' group will be categorized according to their glycemic control by using their glycated haemoglobin (HBA1C) into good control, fair control and poor control

RADIATION

High Resolution Computed Tomography (HRCT)

with the coronavirus disease 2019 Reporting and Data System (CO-RADS) classification grade 5 for SARS COV2 confirmation

DIAGNOSTIC_TEST

Routine Laboratory investigations

* Arterial blood gases (ABGs) * Routine Laboratory investigations (Urea, Creatinine, Liver function tests, Serum Electrolytes, Prothrombin Concentration)

DIAGNOSTIC_TEST

Random Blood Sugar (RBS)

Blood Sugar will be measured before each meal and before bed time during hospitalization.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Martina S. Lamey Eskander, MBBCH. · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-10-01
Completion
2022-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05083013 on ClinicalTrials.gov